Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Freeman

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Cancers|April 30, 2021
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE TrialHayley Pye, Saurabh Singh, Joseph M Norris, et al.
The New England Journal of Medicine|March 20, 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Cancers|April 30, 2021
Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE TrialHayley Pye, Saurabh Singh, Joseph M Norris, et al.
The New England Journal of Medicine|March 20, 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 25